| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |